Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist

Gahlaut Renu; Bennett Aneliese; Fatayer Hiba; Dall Barbara J.; Sharma Nisha; Velikova Galina; Perren Tim; Dodwell David; Lansdown Mark; Shaaban Abeer M.

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist

【24h】

Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist

机译：新辅助化疗对乳腺癌表型，ER / PR和HER2表达的影响-对实践中肿瘤学家的意义

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To assess the effect of neoadjuvant chemotherapy (NACT) on breast cancer characteristics, hormone receptors and human epidermal growth factor receptor 2 (HER2) expression and whether testing should be repeated on residual tumours.

机译：目的：评估新辅助化疗（NACT）对乳腺癌特征，激素受体和人表皮生长因子受体2（HER2）表达的影响，以及是否应对残留肿瘤重复进行测试。

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第null期|共9页
作者
Gahlaut Renu; Bennett Aneliese; Fatayer Hiba; Dall Barbara J.; Sharma Nisha; Velikova Galina; Perren Tim; Dodwell David; Lansdown Mark; Shaaban Abeer M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Neoadjuvant chemotherapy; Breast cancer; Oestrogen receptor; Progesterone receptor; HER2;

机译：新辅助化疗;乳腺癌;雌激素受体;孕激素受体;HER2;

相似文献

外文文献
中文文献
专利

1. Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist [J] . Gahlaut Renu, Bennett Aneliese, Fatayer Hiba, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：新辅助化疗对乳腺癌表型，ER / PR和HER2表达的影响-对实践中肿瘤学家的意义
2. A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients [J] . Risi Emanuela, Grilli Andrea, Migliaccio Ilenia, Breast cancer research and treatment. . 2018,第2期

机译：视网膜母细胞瘤失去功能的基因表达签名预测ER阳性/海绵阳性乳腺癌患者对新辅助化疗的抗性
3. Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer. [J] . M Tanioka, K Sakai, T Sudo, Breast cancer research and treatment. . 2014,第3期

机译：转录CCND1表达可预测曲妥珠单抗对HER2阳性/ ER阳性乳腺癌新辅助化疗反应不良。
4. Immunohistochemistry applications in breast carcinoma: The Hypoxia Inducible Factor lα, Estrogen Receptor, Progesterone Receptor and HER2 expression before and after neoadjuvant chemotherapy [C] . Zuofeng Zhang, Yunai Liang, Chunhua Zhang, Technical Congress on Resources, Environment and Engineering . 2016

机译：免疫组织化学在乳腺癌中的应用：缺氧诱导因子Lα，雌激素受体，孕酮受体和Neoadjuvant化疗前后和Her2表达
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Estrogen receptor (ER) progesterone receptor (PR) and HER2 expression pre- and post- neoadjuvant chemotherapy in primary breast carcinoma: a single institutional experience [O] . Mary Diane Kinsella, Aziza Nassar, Momin T Siddiqui, 2012

机译：新辅助化疗前后原发性乳腺癌的雌激素受体（ER）孕激素受体（PR）和HER2表达：单一机构经验
7. >Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer [O] . Hui Yan, Hui Xiao, Jiujun Zhu, 2020

机译：> HER2蛋白表达水平与Neoadjuvant化疗在Her2阳性乳腺癌中的疗效

Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist

摘要

著录项

相似文献

相关主题

期刊订阅